Loading clinical trials...
Loading clinical trials...
Non-Interventional Post-Authorisation Safety Study of NUCEIVA for the Treatment of Moderate-to-Severe Glabellar Lines
Conditions
Interventions
prabotulinumtoxinA
Locations
1
Germany
Cologne Dermatology
Cologne, Germany
Start Date
March 15, 2023
Primary Completion Date
January 1, 2026
Completion Date
January 1, 2026
Last Updated
August 5, 2025
NCT06411002
NCT05146999
NCT05148000
NCT05277337
NCT04249583
NCT05217355
Lead Sponsor
Evolus, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions